How Severe Are Immunotherapy Adverse Events for Cancer and Preexisting Autoimmune Disease? – Journal of Clinical Pathways
|
How Severe Are Immunotherapy Adverse Events for Cancer and Preexisting Autoimmune Disease?
Journal of Clinical Pathways A recent study summarized the available evidence on adverse events associated with checkpoint inhibitors in patients with cancer and preexisting autoimmune disease, published in the Annals of Internal Medicine (online January 2, 2018; doi:10.7326/M17 … |
